Praveen Tyle
Chairman at KIORA PHARMACEUTICALS, INC.
Net worth: 5 $ as of 31/05/2024
Praveen Tyle active positions
| Companies | Position | Start | End |
|---|---|---|---|
| KIORA PHARMACEUTICALS, INC. | Chairman | 21/09/2023 | - |
| Director/Board Member | 01/06/2008 | 21/09/2023 | |
| Independent Dir/Board Member | 01/06/2008 | 21/09/2023 | |
| ORIENT EUROPHARMA CO., LTD. | Director/Board Member | 16/03/2010 | - |
| Independent Dir/Board Member | 01/01/2003 | - | |
| SKYE BIOSCIENCE, INC. | Director/Board Member | 22/07/2021 | - |
| Independent Dir/Board Member | 22/07/2021 | - | |
Maxwell Biosciences, Inc.
 Maxwell Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Maxwell Biosciences, Inc. operates as biotechnology company for optimizing cognitive performance and health span. The company was founded by Joshua McClure and Annelise Barron in 2016 and is headquartered in Austin, TX. | Director/Board Member | - | - |
Invectys, Inc.
 Invectys, Inc. Pharmaceuticals: MajorHealth Technology Invectys, Inc. is a biopharmaceutical company that focuses on developing immunotherapy treatments for cancer. The private company is based in Houston, TX. Invectys was founded in 2010 and Praveen Tyle has been the CEO of the company since 2021. | Director/Board Member | 04/05/2021 | - |
| Chief Executive Officer | 04/05/2021 | - | |
| President | 04/05/2021 | - | |
Lipomedix Pharmaceuticals Ltd.
 Lipomedix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Lipomedix Pharmaceuticals Ltd. engages in the development of cancer therapy based on liposome delivery. It offers Promitil®, a proprietary formulation of a lipid-based pro-drug of MMC (MLP) which enables efficient delivery and release of active MMC to tumors in vivo. The company was founded by Alberto Gabizon and Rami Kremien and is headquartered in Jerusalem, Israel. | Director/Board Member | 05/08/2019 | - |
Interpath Pharmaceuticals, Inc.
 Interpath Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Interpath Pharmaceuticals, Inc. develops cancer therapeutics based on liposomal delivery technology for antisense. The company was founded in 2001 by Gabriel Lopez-Berestein and Peter Nielsen and is headquartered in Houston, TX | Director/Board Member | - | - |
Career history of Praveen Tyle
Former positions of Praveen Tyle
| Companies | Position | Start | End |
|---|---|---|---|
| LEXICON PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 16/05/2016 | 26/04/2021 |
| Invectys USA, Inc. | Director/Board Member | - | 01/04/2021 |
| Chief Executive Officer | - | 01/04/2021 | |
| President | - | 01/04/2021 | |
| ░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░ ░░░░░░ ░░░░░░ ░░░░░░░░░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░░ ░░░░░░░ ░░░░░░░░░░ ░░ | ░░░░░░░ ░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░ ░ ░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
Training of Praveen Tyle
| The Ohio State University | Doctorate Degree |
| Banaras Hindu University | Undergraduate Degree |
Statistics
International
| United States | 18 |
| Canada | 2 |
| India | 2 |
Operational
| Director/Board Member | 12 |
| Chief Tech/Sci/R&D Officer | 5 |
| Corporate Officer/Principal | 4 |
Sectoral
| Health Technology | 17 |
| Consumer Services | 4 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 5 |
|---|---|
| LEXICON PHARMACEUTICALS, INC. | Health Technology |
| KIORA PHARMACEUTICALS, INC. | Health Technology |
| ORIENT EUROPHARMA CO., LTD. | Health Technology |
| RAMBODA FALLS PLC | Consumer Services |
| SKYE BIOSCIENCE, INC. | Health Technology |
| Private companies | 15 |
|---|---|
Bausch & Lomb, Inc.
 Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | Health Technology |
Aronex Pharmaceuticals, Inc.
 Aronex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aronex Pharmaceuticals, Inc. develops proprietary medicines to treat cancer and infectious diseases. The company's products include Nyotran, Atragen, Annamycin, and Zintevir. It is headquartered in The Woodlands, TX. | Health Technology |
Biovail Corp.
 Biovail Corp. Pharmaceuticals: MajorHealth Technology Biovail Corp. develops and manufactures pharmaceutical products. The company provides different types of products which include Wellbutrin SR, Retavase, Zyban and Tiazac XC in Canada and Zovirax Ointment and Zovirax Cream in the United States. Its products are used for cardiovascular disease, central nervous system disorders, pain management and other niche areas. It was founded on March 29, 1994 and is headquartered in Mississauga, Canada. | Health Technology |
GI Dynamics, Inc.
 GI Dynamics, Inc. Medical SpecialtiesHealth Technology GI Dynamics, Inc. engages in the development and commercialization of a medical device system intended for treatment of patients with type 2 diabetes and reduction of obesity. Its pipeline product is EndoBarrier, an endoscopically delivered medical device intended to help restore healthy blood sugar levels and reduce weight. The company was founded by Andy Levine on March 24, 2003 and is headquartered in Boston, MA. | Health Technology |
Interpath Pharmaceuticals, Inc.
Interpath Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Interpath Pharmaceuticals, Inc. develops cancer therapeutics based on liposomal delivery technology for antisense. The company was founded in 2001 by Gabriel Lopez-Berestein and Peter Nielsen and is headquartered in Houston, TX | Health Technology |
Graybug Vision, Inc.
 Graybug Vision, Inc. Pharmaceuticals: MajorHealth Technology Graybug Vision, Inc. develops ophthalmic drugs. It focus on developing drug delivery therapies for the treatment of eye diseases such as age-related macular degeneration and glaucoma. The company was founded by Justin S. Hanes, Peter John McDonnell, Christy Wyskiel and Peter A. Campochiaro in May 2011 and is headquartered in Redwood City, CA. | Health Technology |
Arsenal Capital Management LP
 Arsenal Capital Management LP Investment ManagersFinance Arsenal Capital Management LP (Arsenal Capital) is a private equity subsidiary of Arsenal Capital Group LLC founded in 2000 by Terrence M. Mullen and Jeffrey B. Kovach. The firm is headquartered in New York. | Finance |
Pharmacia Corp.
 Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ. | Health Technology |
Osmotica Pharmaceutical Corp.
 Osmotica Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Osmotica Pharmaceutical Corp. provides drug delivery technologies and neurology based therapies. It develops and commercializes a portfolio of products related to central nervous system disorders with a focus in Parkinson's disease and related neurological disorders. The company was founded in 1986 and is headquartered in Bridgewater, GA. | Health Technology |
Novartis Consumer Health, Inc.
 Novartis Consumer Health, Inc. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Novartis Consumer Health, Inc. manufactures and supplies pharmaceutical products. The company is based in Lincoln, NE. | Health Technology |
The United States Pharmacopeia
 The United States Pharmacopeia Pharmaceuticals: MajorHealth Technology The United States Pharmacopeia engages in manufacturing medicines. It offers dietary supplements, and foods. The company is headquartered in Rockville, MD. | Health Technology |
Lipomedix Pharmaceuticals Ltd.
Lipomedix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Lipomedix Pharmaceuticals Ltd. engages in the development of cancer therapy based on liposome delivery. It offers Promitil®, a proprietary formulation of a lipid-based pro-drug of MMC (MLP) which enables efficient delivery and release of active MMC to tumors in vivo. The company was founded by Alberto Gabizon and Rami Kremien and is headquartered in Jerusalem, Israel. | Health Technology |
Maxwell Biosciences, Inc.
Maxwell Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Maxwell Biosciences, Inc. operates as biotechnology company for optimizing cognitive performance and health span. The company was founded by Joshua McClure and Annelise Barron in 2016 and is headquartered in Austin, TX. | Commercial Services |
Invectys, Inc.
Invectys, Inc. Pharmaceuticals: MajorHealth Technology Invectys, Inc. is a biopharmaceutical company that focuses on developing immunotherapy treatments for cancer. The private company is based in Houston, TX. Invectys was founded in 2010 and Praveen Tyle has been the CEO of the company since 2021. | Health Technology |
| Invectys USA, Inc. |
- Stock Market
- Insiders
- Praveen Tyle
- Experience
